Teresa A.
- Country
- Germany
- Department
- Dermatology
Research Overview
- Phase 1b/II Multicenter Trial of Neoadjuvant Intradermal Ipilimumab and Nivolumab in High-Risk Stage II Melanoma Patients
- Evaluation of Belvarafenib Monotherapy and Combination Therapy with Cobimetinib and Nivolumab in NRAS-Mutant Advanced Cutaneous Melanoma Patients
- A Phase 3, Randomized, Open-label, Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination versus Intravenous Nivolumab + Relatlimab Fixed-dose Combination in Participants with Previously Untreated Metastatic or Unresectable Melanoma
Data & Insights
Has run more than one trial at 80 of 192 partner sites.
Specializations
Dermatologic Oncology
Clinical research activity is centered on cutaneous malignancies, with involvement in studies of melanoma, cutaneous squamous cell carcinoma, and basal cell carcinoma. The portfolio also includes advanced and unresectable skin cancers, reflecting a strong therapeutic focus on malignancies arising in the skin and their management through modern oncologic treatment strategies.
- Melanoma
- Cutaneous Squamous Cell Carcinoma
- Basal Cell Carcinoma
- Merkel Cell Carcinoma
Research interest extends to locally advanced, metastatic, and resectable disease settings, with emphasis on improving outcomes in complex skin cancer care.
Breast and Gynecologic Oncology
The investigator is involved in breast cancer and gynecologic cancer research, including triple-negative breast cancer, hormone receptor-positive breast cancer, HER2-positive early breast cancer, ovarian cancer, and endometrial cancer. This area also includes biomarker-oriented treatment approaches in early and advanced disease.
- Breast Cancer
- Triple-Negative Breast Cancer
- Ovarian Cancer
- Endometrial Cancer
Therapeutic interest spans early-stage, locally advanced, and metastatic disease, with attention to innovation in systemic treatment for women’s cancers.
Hematologic Malignancies
Research activities include acute leukemia, myelodysplastic syndromes, multiple myeloma, and lymphoma, covering both newly diagnosed and relapsed or refractory settings. The portfolio reflects broad engagement across malignant disorders of the blood and bone marrow.
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Multiple Myeloma
- Diffuse Large B-Cell Lymphoma
There is also involvement in stem cell transplantation-related research and other advanced hematologic treatment domains.
Urologic and Thoracic Oncology
The investigator contributes to studies in urothelial carcinoma, renal cell carcinoma, prostate cancer, and non-small cell lung cancer. This research landscape includes both localized and metastatic solid tumors with distinct therapeutic needs.
- Urothelial Carcinoma
- Renal Cell Carcinoma
- Prostate Cancer
- Non-Small Cell Lung Cancer
Clinical interest is also evident in treatment-resistant and biomarker-defined disease, supporting precision-oriented oncology care.
Immune-Mediated and Inflammatory Disease
Beyond oncology, the investigator is involved in trials across psoriasis, atopic dermatitis, ulcerative colitis, Crohn’s disease, and systemic lupus erythematosus. The scope includes chronic immune-mediated disorders affecting the skin, gastrointestinal tract, and connective tissue.
- Psoriasis
- Atopic Dermatitis
- Ulcerative Colitis
- Crohn’s Disease
These activities indicate therapeutic interest in inflammatory disease control and the development of targeted immune-based treatment options.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.